Clinical Trial Update: Study of an Investigational Product, QLS-111, Provided as an Eyedrop, for Treatment of Normal Tension Glaucoma (NTG) [Phase 2]

View source ↗

Summary

This ClinicalTrials.gov update indicates that the Phase 2 trial of the investigational eyedrop QLS-111 for normal tension glaucoma has completed. The study also…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Low-tension Glaucoma
• Normal Tension Glaucoma

Drugs mentioned

• QLS-111 (QLS-111)

Snippet

Sponsor: Qlaris Bio, Inc. | Conditions: Normal Tension Glaucoma (NTG), Low-Tension Glaucoma, Bilateral | Phase 2 | Status: COMPLETED